Milestone Pharmaceuticals Inc logo

Milestone Pharmaceuticals Inc

1
NAS:MIST (Canada)  
$ 1.71 -0.04 (-2.29%) 10:08 PM EST
At Loss
P/B:
2.28
Market Cap:
$ 91.08M
Enterprise V:
$ 54.10M
Volume:
78.82K
Avg Vol (2M):
182.80K
Volume:
78.82K
At Loss
Avg Vol (2M):
182.80K

Business Description

Description
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
Name Current Vs Industry Vs History
Cash-To-Debt 1.7
Equity-to-Asset 0.42
Debt-to-Equity 1.32
Debt-to-EBITDA -1.02
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 38.93
9-Day RSI 48.28
14-Day RSI 50.57
6-1 Month Momentum % -39.86
12-1 Month Momentum % -61.4

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 22.75
Quick Ratio 22.75
Cash Ratio 21.67

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.9
Shareholder Yield % -71.5

Financials (Next Earnings Date:2024-08-09 Est.)

MIST's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:MIST

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Milestone Pharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1
EPS (TTM) ($) -1.25
Beta 0.05
Volatility % 75.78
14-Day RSI 50.57
14-Day ATR ($) 0.078208
20-Day SMA ($) 1.70225
12-1 Month Momentum % -61.4
52-Week Range ($) 1.33 - 4.14
Shares Outstanding (Mil) 53.26

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Milestone Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Milestone Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Milestone Pharmaceuticals Inc Frequently Asked Questions

What is Milestone Pharmaceuticals Inc(MIST)'s stock price today?
The current price of MIST is $1.71. The 52 week high of MIST is $4.14 and 52 week low is $1.33.
When is next earnings date of Milestone Pharmaceuticals Inc(MIST)?
The next earnings date of Milestone Pharmaceuticals Inc(MIST) is 2024-08-09 Est..
Does Milestone Pharmaceuticals Inc(MIST) pay dividends? If so, how much?
Milestone Pharmaceuticals Inc(MIST) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1